Using_VBG
nothing_INPR
more_EMPH
than_PIN
a_DT
simple_JJ
vial_NN
of_PIN
saliva_NN
,_,
millions_NN
of_PIN
people_NN
have_VPRT [PEAS]
created_VBN
DNA_NN
profiles_NN
on_PIN
genealogy_NN
websites_NN
._.
But_CC
this_DEMO
wealth_NN
of_PIN
information_NOMZ
is_VPRT [BEMA]
effectively_RB
inaccessible_PRED
to_PIN
genetics_NN
researchers_NN
,_,
with_PIN
the_DT
sites_NN
painstakingly_RB
safeguarding_VBG
their_TPP3
databases_NN
,_,
fearful_JJ
of_PIN
a_DT
leak_NN
that_TSUB
could_POMD
cost_VB
them_TPP3
dearly_RB
in_PIN
terms_NN
of_PIN
credibility_NOMZ
._.
This_DEMO
problem_NN
of_PIN
access_NN
is_VPRT [BEMA]
one_CD
that_DEMO
Bonnie_NN
Berger_NN
,_,
a_DT
professor_NN
of_PIN
mathematics_NN
at_PIN
the_DT
Massachusetts_NN
Institute_NN
of_PIN
Technology_NN
,_,
and_ANDC
her_TPP3
colleagues_NN
think_VPRT [PRIV] [THATD]
they_TPP3
can_POMD
solve_VB
,_,
with_PIN
a_DT
new_JJ
cryptographic_JJ
system_NN
to_TO
protect_VB
the_DT
information_NOMZ
._.
``_``
We_FPP1
're_VPRT [CONT] [BEMA]
currently_RB
at_PIN
a_DT
stalemate_NN
in_PIN
sharing_VBG
all_QUAN
this_DEMO
genomic_JJ
data_NN
,_,
''_''
Berger_NN
told_VBD
AFP_NN
._.
``_``
It_PIT
's_VPRT [CONT] [BEMA]
really_EMPH
hard_PRED
for_PIN
researchers_NN
to_TO
get_VB
any_QUAN
of_PIN
their_TPP3
data_NN
,_,
so_IN
they_TPP3
're_VPRT [CONT]
not_XX0
really_EMPH
helping_VBG
science_NN
._.
''_''
``_``
No_SYNE
one_NN
can_POMD
gain_VB
access_NN
to_TO
help_VB
them_TPP3
find_VB [PRIV]
the_DT
link_NN
between_PIN
genetic_JJ
variations_NOMZ
and_PHC
disease_NN
,_,
''_''
she_TPP3
said_VBD [PUBV]
._.
``_``
But_CC
just_EMPH
think_VB [PRIV]
what_WP
could_POMD
happen_VB
if_COND
we_FPP1
could_POMD
leverage_NN
the_DT
millions_NN
of_PIN
genomes_NN
out_PIN
there_RB
._.
''_''
The_DT
idea_NN
of_PIN
this_DEMO
new_JJ
cryptographic_JJ
method_NN
,_,
described_VBN
Thursday_NN
in_PIN
the_DT
US_FPP1
journal_NN
Science_NN
,_,
was_VBD [PASS]
developed_VBN
in_PIN
connection_NOMZ
to_TO
finding_VBG [PRIV]
drug_NN
candidates_NN
in_PIN
datasets_NN
from_PIN
pharmaceuticals_NN
companies_NN
._.
In_PIN
an_DT
earlier_TIME
work_NN
,_,
the_DT
researchers_NN
have_VPRT [PEAS]
shown_VBN [PRIV] [THATD]
the_DT
concept_NN
could_POMD
be_VB [PASS]
applied_VBN
to_PIN
DNA_NN
profiles_NN
._.
Labs_NN
are_VPRT [SPAU]
constantly_RB
looking_VBG
to_TO
identify_VB
links_NN
between_PIN
millions_NN
of_PIN
drug_NN
compounds_NN
and_CC
the_DT
tens_NN
of_PIN
thousands_NN
of_PIN
proteins_NN
in_PIN
the_DT
human_JJ
body_NN
,_,
to_TO
identify_VB
good_JJ
candidates_NN
for_PIN
certain_JJ
drugs_NN
._.
But_CC
they_TPP3
do_VPRT
n't_XX0 [CONT]
want_VB
their_TPP3
competitors_NN
to_TO
know_VB [PRIV]
what_WP [WHCL]
they_TPP3
are_VPRT
working_VBG
on_PIN [STPR]
._.
Often_RB
,_,
their_TPP3
drug_NN
compounds_NN
are_VPRT [PASS]
patented_VBN
and_CC
secret_JJ
._.
So_IN
they_TPP3
do_VPRT
n't_XX0 [CONT]
share_VB
much_QUAN
._.
-_:
`_``
Secret_JJ
sharing_GER
'_''
-_:
With_PIN
the_DT
researchers_NN
'_POS
new_JJ
scalable_JJ
technique_NN
,_,
the_DT
first_JJ
based_VBN
on_PIN
a_DT
secure_JJ
``_``
neural_JJ
network_NN
,_,
''_''
Berger_NN
explained_VBD [PUBV]
,_,
labs_NN
could_POMD
share_VB
their_TPP3
sensitive_JJ
data_NN
,_,
dividing_VBG [PRESP]
it_PIT
between_PIN
several_QUAN
servers_NN
that_TSUB
would_PRMD
run_VB
to_TO
find_VB [PRIV] [THATD]
new_JJ
links_NN
based_VBN [WZPAST]
on_PIN
the_DT
data_NN
sample_NN
as_IN
a_DT
whole_NN
._.
But_CC
no_SYNE
entity_NOMZ
would_PRMD
be_VB [BEMA]
able_PRED
to_TO
access_VB
the_DT
initial_JJ
inputs_NN
,_,
which_WDT [SERE]
might_POMD
include_VB
proprietary_JJ
information_NOMZ
--_:
provided_VBN
they_TPP3
do_VPRT
n't_XX0 [CONT]
decide_VB [SUAV] [PRIV]
to_TO
collude_VB
with_PIN
each_QUAN
other_JJ
._.
Each_QUAN
entity_NOMZ
would_PRMD
get_VB
results_NN
based_VBN [WZPAST]
on_PIN
its_PIT
contributions_NOMZ
._.
Berger_NN
says_VPRT [PUBV] [THATD]
their_TPP3
technique_NN
is_VPRT [PASS]
based_VBN
on_PIN
a_DT
cryptographic_JJ
framework_NN
called_VBN
``_``
secret_JJ
sharing_GER
._.
''_''
The_DT
researchers_NN
introduced_VBD
new_JJ
optimization_NOMZ
and_CC
artificial_JJ
intelligence_NN
techniques_NN
to_TO
be_VB [BEMA]
able_PRED
to_TO
handle_VB
the_DT
millions_NN
of_PIN
chemical_NN
compounds_NN
or_CC
genomes_NN
that_TSUB
need_VPRT
to_TO
be_VB [PASS]
analyzed_VBN
._.
``_``
We_FPP1
can_POMD
do_VB
something_QUPR
that_DEMP
was_VBD
absolutely_AMP
not_XX0
possible_JJ
before_IN
,_,
''_''
the_DT
MIT_NN
professor_NN
said_VBD [PUBV]
,_,
noting_VBG [PRIV] [THATD]
that_DEMP
existing_VBG
cryptographic_JJ
methods_NN
involve_VPRT
unwieldy_JJ
large-scale_JJ
computer_NN
calculations_NOMZ
and_PHC
communications_NOMZ
costs_NN
._.
They_TPP3
also_RB
only_DWNT
work_VB
for_PIN
thousands_NN
of_PIN
data_NN
points_NN
,_,
not_XX0
millions_NN
._.
The_DT
same_JJ
technique_NN
could_POMD
allow_VB [SUAV]
the_DT
major_JJ
genealogy_NN
websites_NN
,_,
like_IN
Ancestry.com_NN
and_PHC
23andMe_NN
,_,
to_TO
open_VB
their_TPP3
databases_NN
to_PIN
researchers_NN
and_CC
pool_VB
them_TPP3
._.
Ancestry_NN
has_VPRT
more_EMPH
than_PIN
10_CD
million_CD
registered_VBN
profiles_NN
,_,
while_OSUB
23andMe_NN
has_VPRT
more_EMPH
than_PIN
five_CD
million_CD
._.
Berger_NN
told_VBD
AFP_NN
she_TPP3
had_VBD [PEAS]
been_VBN [BEMA]
in_PIN
contact_NN
with_PIN
both_DT
companies_NN
about_IN
her_TPP3
findings_GER
._.
Ancestry_NN
,_,
23andMe_NN
,_,
MyHeritage_NN
and_PHC
others_NN
offer_VPRT
physical_JJ
,_,
genealogical_JJ
and_CC
sometimes_RB
even_RB
medical_JJ
data_NN
--_:
such_JJ
as_IN
a_DT
history_NN
of_PIN
cancer_NN
in_PIN
the_DT
family_NN
._.
It_PIT
is_VPRT [BEMA]
this_DEMO
information_NOMZ
that_TOBJ
researchers_NN
want_VPRT
to_TO
match_VB
against_PIN
certain_JJ
genetic_JJ
variations_NOMZ
._.
23andMe_NN
has_VPRT [PEAS]
taken_VBN
a_DT
step_NN
in_PIN
this_DEMO
direction_NOMZ
,_,
via_PIN
a_DT
partnership_NN
with_PIN
pharmaceuticals_NN
group_NN
GlaxoSmithKline_NN
-LRB-_-LRB-
GSK_NN
-RRB-_-RRB-
._.
A_DT
23andMe_JJ
spokesman_NN
told_VBD
AFP_NN
that_TOBJ
scientific_JJ
collaborations_NOMZ
have_VPRT [PEAS]
led_VBN
to_PIN
the_DT
publication_NOMZ
of_PIN
about_IN
100_CD
research_NN
articles_NN
._.
But_CC
the_DT
company_NN
only_DWNT
offers_VPRT
researchers_NN
a_DT
statistical_JJ
summary_NN
of_PIN
the_DT
results_NN
,_,
in_PIN
this_DEMO
format_NN
:_:
``_``
30_CD
percent_NN
of_PIN
males_NN
aged_VBN
20-35_CD
have_VPRT [PEAS]
reported_VBN [PUBV]
being_VBG [PASS]
diagnosed_VBN
with_PIN
X_NN
disease_NN
and_CC
have_VPRT
Y_NN
variants\/mutations_NOMZ
in_PIN
common_JJ
._.
''_''
And_ANDC
user_NN
participation_NOMZ
is_VPRT [BEMA]
on_PIN
a_DT
voluntary_JJ
basis_NN
,_,
which_WDT [SERE]
limits_VPRT
the_DT
scope_NN
of_PIN
the_DT
findings_GER
._.
-_:
Privacy_NN
concerns_NN
-_:
The_DT
intersection_NOMZ
of_PIN
genetics_NN
and_PHC
genealogy_NN
has_VPRT [PEAS]
made_VBN
headlines_NN
in_PIN
the_DT
United_NN
States_NN
._.
Last_JJ
week_NN
,_,
a_DT
new_JJ
study_NN
showed_VBD [PRIV]
that_THVC
half_NN
of_PIN
all_QUAN
Americans_NN
could_POMD
be_VB [PASS]
identified_VBN
from_PIN
relatives_NN
'_POS
DNA_NN
samples_NN
found_VBN [PRIV] [WZPAST]
in_PIN
GEDmatch_NN
,_,
a_DT
free_JJ
website_NN
._.
This_DEMO
technique_NN
has_VPRT [PEAS]
been_VBN [BEMA]
a_DT
boon_NN
for_PIN
US_FPP1
police_NN
forces_NN
,_,
who_WP
have_VPRT [PEAS]
used_VBN
it_PIT
to_TO
identify_VB
suspects_NN
in_PIN
cold_JJ
cases_NN
dating_VBG [WZPRES]
back_RB
decades_NN
,_,
such_JJ
as_IN
the_DT
``_``
Golden_NN
State_NN
Killer_NN
,_,
''_''
who_WP
is_VPRT [PASS]
blamed_VBN
for_PIN
12_CD
murders_NN
and_CC
more_EMPH
than_PIN
50_CD
rapes_NN
starting_VBG [WZPRES]
in_PIN
the_DT
mid-1970s_NN
._.
It_PIT
can_POMD [SPAU]
also_RB
be_VB [BYPA]
used_VBN
by_PIN
people_NN
looking_VBG [WZPRES]
for_PIN
their_TPP3
biological_JJ
parents_NN
._.
But_CC
what_WP
happens_VPRT
if_COND
the_DT
data_NN
falls_VPRT
into_PIN
the_DT
wrong_JJ
hands_NN
?_.
Hackers_NN
could_POMD [SPAU]
potentially_RB
exploit_VB
the_DT
information_NOMZ
to_PIN
nefarious_JJ
ends_NN
._.
Or_CC
what_WP
if_COND
insurance_NN
companies_NN
and_PHC
others_NN
used_VBD
it_PIT
to_PIN
discriminate_JJ
against_PIN
customers_NN
?_.
Benjamin_NN
Berkman_NN
,_,
a_DT
bioethics_NN
researcher_NN
at_PIN
the_DT
National_NN
Institutes_NN
of_PIN
Health_NN
,_,
told_VBD
AFP_NN
there_EX
is_VPRT
``_``
not_XX0
really_EMPH
evidence_NN
of_PIN
systemic_JJ
discrimination_NOMZ
,_,
''_''
but_CC
noted_VBD [PRIV] [THATD]
that_DEMP
``_``
does_VPRT
n't_XX0 [CONT]
mean_VB [PRIV]
that_THVC
it_PIT
could_POMD
n't_XX0 [CONT]
become_VB
a_DT
problem_NN
._.
''_''
``_``
People_NN
are_VPRT [BEMA]
very_AMP
worried_PRED
about_IN
genomic_JJ
privacy_NN
._.
It_PIT
's_VPRT [CONT]
something_QUPR
that_DEMO
they_TPP3
cite_VPRT
as_IN
a_DT
reason_NN
why_RB
they_TPP3
're_VPRT [CONT]
not_XX0
getting_VBG
genetic_JJ
testing_GER
,_,
or_CC
they_TPP3
're_VPRT [CONT]
not_XX0
enrolling_VBG
in_PIN
research_NN
,_,
''_''
Berkman_NN
said_VBD [PUBV]
._.
